MannKind Corporation logo

MannKind Corporation

Brand

3.6

Company overview

MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.Please visit mannkindcorp.com to learn more.
Founded in 1991
Danbury, Connecticut, USA
803 employees (22 in marketing)
www.mannkindcorp.com
79% recommend to a friend
81% positive business outlook

Salaries

Typical salary range

$184,000 – $276,000

/ yr

Help build salary transparency at MannKind Corporation

Share your compensation anonymously to see full data.

Contribute

People

Founders and leadership

Michael Castagna
Michael Castagna
Chief Executive Officer
At the company for 10 years 5 months

Marketing leadership

Tara Hendrzak
Tara Hendrzak
VP of Marketing
At the company for 7 months
Stuart Tross
Stuart Tross
Chief People & Workplace Officer & EVP (Responsible for HR, Internal Comms & Office Facilities)
At the company for 9 years 8 months
Joan Rogers
Joan Rogers
Head of Marketing, Endocrine Business Unit
At the company for 2 years 9 months
Mary Rowell
Mary Rowell
Associate Director, Patient Marketing
At the company for 9 months

Hiring contacts

Andrew Garrison
Andrew Garrison
Senior Associate Manager, Talent Acquisition
At the company for 3 years 5 months
Karen Marnell
Karen Marnell
Senior Talent Acquisition Specialist
At the company for 5 years 1 month

Hiring activity

Open marketing jobs over time

15 open now

Headcount trend

Company growth over the last 12 months

Headcount +8.8% year over year

Funding

Total funding

$475M

Last raise

$75M

Post IPO Debt, 7 months ago

Funding history

Aug 2025

Post IPO Debt MannKind · $75M

Mar 2021

Post IPO Debt MannKind · $200M

Dec 2018

Post IPO Equity MannKind · $40M

Jul 2013

Post IPO Debt MannKind · $160M

Audience

Monthly website visitors
14.4K
Month over month-17.2%
Quarter over quarter-14.9%
Top sourceSearch (45%)
Ad budget per month$0.0
Average search rank58.5
Traffic source mix
Search
45%
Direct
40.4%
Referral
7.5%
Social
5.6%
Paid referral
1.4%

LinkedIn followers

Follower count and growth

Total followers

19.6K

12-mo growth

+42.2%

Monthly growth

+3.5%

News

Links

www.mannkindcorp.comLinkedInCrunchbaseX (Twitter)
Glassdoor